Effect of a Proton Pump Inhibitor on the PK of Tepotinib
Clinical trial NCT03531762 · COMPLETED
Trial details
- NCT number
- NCT03531762
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2018-07-02
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.